BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 924761)

  • 1. Establishment in continuous culture and characterization of cell surface markers, and other immunologic and virologic properties of lymphoblastoid cells derived from patients with different types of lymphoma.
    Goldblum N
    Isr J Med Sci; 1977 Jul; 13(7):725-30. PubMed ID: 924761
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. I. Physical, cytogenetic, and growth characteristics.
    Magrath IT; Pizzo PA; Whang-Peng J; Douglass EC; Alabaster O; Gerber P; Freeman CB; Novikovs L
    J Natl Cancer Inst; 1980 Mar; 64(3):465-76. PubMed ID: 6243721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cytogenetics of the lymphomas].
    San Román C
    Rev Esp Oncol; 1982; 29(3):457-61. PubMed ID: 6765348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cytogenetic of malignant lymphomas].
    Fonatsch C
    Dtsch Med Wochenschr; 1982 Mar; 107(12):468-71. PubMed ID: 7060482
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunological reactions to tumor-associated antigens in Burkitts lymphoma and other lymphomas.
    Herberman RB; McCoy JL; Levine PH
    Cancer Res; 1974 May; 34(5):1222-7. PubMed ID: 4366992
    [No Abstract]   [Full Text] [Related]  

  • 6. Aberrations of chromosome 3. A marker of T-cell lymphomas?
    Gödde-Salz E
    J Genet Hum; 1983 Mar; 31(1):39-44. PubMed ID: 6604789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
    Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML
    Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electron microscopic and cytogenetic studies of cells derived from Burkitt's lymphoma.
    Toshima S; Takagi N; Minowada J; Moore GE; Sandberg AA
    Cancer Res; 1967 Apr; 27(4):753-9. PubMed ID: 6025733
    [No Abstract]   [Full Text] [Related]  

  • 9. Stable nontumorigenic phenotype of somatic cell hybrids between malignant Burkitt's lymphoma cells and autologous EBV-immortalized B cells despite induction of chromosomal breakage and loss.
    Jox A; Taquia E; Vockerodt M; Draube A; Pawlita M; Möller P; Bullerdiek J; Diehl V; Wolf J
    Cancer Res; 1998 Nov; 58(21):4930-9. PubMed ID: 9810002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial cytogenetic studies of nonendemic Burkitt's lymphoma cell lines.
    Douglass EC; Magrath IT; Lee EC; Whang-Peng J
    J Natl Cancer Inst; 1980 Nov; 65(5):891-5. PubMed ID: 6253706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic markers of Burkitt's lymphoma cells.
    Preud'homme JL; Dellagi K; Guglielmi P; Vogler LB; Danon F; Lenoir GM; Valensi F; Brouet JC
    IARC Sci Publ; 1985; (60):47-64. PubMed ID: 3864747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. II. Surface markers.
    Magrath IT; Freeman CB; Pizzo P; Gadek J; Jaffe E; Santaella M; Hammer C; Frank M; Reaman G; Novikovs L
    J Natl Cancer Inst; 1980 Mar; 64(3):477-83. PubMed ID: 6243722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of lymphomatous cell lines from bone marrow samples from patients with Burkitt's lymphoma.
    Philip I; Philip T; Favrot M; Vuillaume M; Fontaniere B; Chamard D; Lenoir GM
    J Natl Cancer Inst; 1984 Oct; 73(4):835-40. PubMed ID: 6090749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chromosome studies on lymph node cultures from patients with malignant lymphoma].
    Fleischmann T; Håkansson CH; Gustafsson T
    Orv Hetil; 1975 Oct; 116(42):2463-9. PubMed ID: 1103057
    [No Abstract]   [Full Text] [Related]  

  • 15. Chromosome serial studies of a cultured cell line (GH 7 ) from a human lymphosarcoma.
    Brieux de Salum S; Suarez HG; Pavlovsky A
    Rev Eur Etud Clin Biol; 1971; 16(7):711-4. PubMed ID: 5171132
    [No Abstract]   [Full Text] [Related]  

  • 16. The cytogenetics of human B lymphoid malignancy: studies in Burkitt's lymphoma and Epstein-Barr virus-transformed lymphoblastoid cell lines.
    Steel CM; Morten JE; Foster E
    IARC Sci Publ; 1985; (60):265-92. PubMed ID: 2998993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphomas and dysproteinaemias.
    Atkin NB
    Clin Haematol; 1980 Feb; 9(1):175-93. PubMed ID: 6768482
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparison of cytogenetics and histopathology in the malignant lymphomata.
    Lawler SD; Reeves BR; Hamlin IM
    Br J Cancer Suppl; 1975 Mar; 2():162-7. PubMed ID: 1182067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viruses and lymphoma/leukaemia.
    Jarrett RF
    J Pathol; 2006 Jan; 208(2):176-86. PubMed ID: 16362996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment and characterisation of two novel human KSHV- and EBV-negative Burkitt cell lines, GAL-01 and GAL-02, from a primary lymphomatous effusion.
    Thielen C; Herens C; Fassotte MF; Detrooz E; Drion P; Diss T; Boniver J; de Leval L
    Eur J Haematol; 2006 Oct; 77(4):318-26. PubMed ID: 16856916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.